CORRELATION OF HAEMATOLOGICAL PROFILE AND SICKLE CELL DISEASE: A STUDY IN RAIPUR AND DURG DISTRICTS OF CHHATTISGARH
DOI:
https://doi.org/10.48047/6wpy2b98Keywords:
Chhattisgarh, Haematological profile, Sickle cell disease, Cross-sectional, ASPCR, ERMAAbstract
Sickle cell disease is an inherited structural disorder of hemoglobin and a major public health issue in the state of Chhattisgarh, India. Government of Chhattisgarh passed ‘Sickle cell bill’ in the Assembly looking to its previous impact on society. The present study was executed on sickle cell disease patients and controls. A cross-sectional study was done for screening of sickle cell hemoglobin with individual informed written consent, 90 subjects of Raipur & Durg districts, belonging to different caste category, ranging in age between 1.5year to 45 year were screened using 2% sodium meta bisulphate solution. Genotype of individuals with sickle cell hemoglobin as done by Allele specific polymerase chain reaction (ASPCR) analysis and normal individuals were treated as control. ERMA total blood cell counter machine (PCE-210) was used for the analysis of various hematological parameters.
The study focused on two aspects. Firstly, mutant beta chain of HbSS was distinguished form normal beta chain of HbAA by using technique of PCR followed by gel electrophoresis. Secondly HbSS, HbAS & HbAA individuals correlated with various hematological indices. We found significant statistical difference for hematological indices – DLC, Leucocytes, bleeding time & clotting time between Sickle cell patients (HbSS & HbAS) & controls.
Downloads
References
Adler, B. K.; Salzman, D. E.; Carabasi, M. H.; Vaughan, W. P.; Reddy, V. V. B.; Prchal, J. T. :Adorno EV, Zanette A, Lyra I, Souza CC, Santos LF, Menezes JF, Dupuit MF, Almeida MN, Reis MG and Goncalves MS (2004) The beta-globin gene cluster haplotypes in sickle cell anemia from Northeast Brazil: A clinical and molecular view. Hemoglobin 28:267-271.
Ambekar SS, Phadke MA, Mokashi GD, Bankar MP, Khedkar VA, Venkat V et al. Pattern of Hemoglobinopathies in western Maharashtra. Indian Pediatr 2001; 38: 530-534.
Ashley-Koch, Q. Yang, and R. S. Olney. 1998."Hemoglobin S Allele and Sickle Cell Disease." American Journal of Epidemiology 151 (9): 839-45. (September 2003).
Böttiger LE, Svedberg CA (1967). "Normal erythrocyte sedimentation rate and age". Br Med J 2 (5544): 85–7. doi:10.1136/bmj.2.5544.85.
Balgir RS, Mishra RK, Murmu B. Clinical and hematological profile of hemoglobino- pathies in two tribal communities of Sundargarh district in Orissa, India. Int J Hum Genet 2003; 3:209-216.
Balgir RS, Sharma SK. Distribution of sickle cell hemoglobin in India. Ind J Hematol 1988;6:114.
Balgir RS. Genetic epidemiology of the three predominant abnormal hemoglobins in India. JAPI 1996; 44: 25-8.
Balgir RS. Scenario of hemoglobin variants in Central-East coast of India. Curr Sci 2006; 90:1651-1657.
Balgir RS. Spectrum of hemoglobinopathies in the state of Orissa, India: A ten years cohort study. J Assoc Phys India 2005; 53:1021-1026.
Balgir RS. The body mass index in sickle cell hemoglobinopathy. J Ind Anthrop Soc 1993;28:147-50.
Buchanan GR, Debaun MR, Quinn CT and Steinberg MH (2004) Sickle cell disease. Hematology Am Soc Hematol 35-47.
Dacie JV, Lewis SM. Practial Hematology. 6th Ed. Edinburgh: Churchill Livingstonel; 1984.
Dacie JV, Lewis SM. Practical Hematology. 7th Edn. Edinburgh: Churchill Livingstone 1991,pp.227-258.
Davis H, Moore RM Jr, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep 112(1): 40-43 (1997).
Davie EW, Ratnoff OD (1964). "Waterfall sequence for intrinsic blood clotting". Science 145: 1310–2. doi:10.1126/science.145.3638.1310.
De M, Das SK, Bhattarcharya DK, Talukder G. The occurrence of Beta-thalassemia mutation and its interaction with hemoglobin E in the Eastern India. Int J Hemat 1997; 66: 31-34.
Figueiredo MS, Kerbauy J, Goncalves MS, Arruda VR, Saad ST, Sonati MF, Stoming T and Costa FF (1996) Effect of α-thalassemia and β globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia Brazil. Am J Hematol 53:72-76.
Frenette S.Paul and Atweeh F George; Sickle cell disease: old discoveries, new concepts, and future promise; 2007; Division of Hematology/Oncology, Mount Sinai School of Medicine, New York, New York, USA.
Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia: molecular biology and clinical medicine. Hemoglobin 1997; 21:299-319.
Herrick, J. B. : Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch. Intern. Med. 6: 517-521, 1910.
International Council for Standardization in Haematology (Expert Panel on Blood Rheology) (1993). "ICSH recommendations for measurement of erythrocyte sedimentation rate.". J. Clin. Pathol. 46 (3): 198–203.
M Kaur; Sickle cell trait & disease among tribal communities in Orissa, Madhya Pradesh & Kerala, 1997; Indian J Med Res.
Mohanty D: Sickle Cell Anemia - The Indian Scenario. Ind. J. Hematol. 16,1:1 (1998).
Mukherjee MB, Surve RR, Ghosh K, et al. Clinical diversity of sickle cell disease in Western India - Influence of genetic factors. Acta Hematol 2000; 103:122-3.
Nagel RL and Ranney HM. Genetic epidemiology of structural mutations of the beta-globin gene. Semin Hematol 27(4): 342-359 (1990).
Nagel RL and Steinberg MH (2001a) Genetics of the βS gene: Origins, genetic epidemiology, and epistasis in sickle cell anemia. In: Steinberg MH, Forget BG, Higgs DR and Nagel RL (eds) Disorders of Hemoglobin - Genetics, Pathophysiology, and Clinical Management. Cambridge University Press, New York, pp 711-755.
Ohene - Frempong K, Steinberg MH. Clinical aspects of sickle cell anemia in adults and children. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors, Disorders of Hemoglobin, 1st Ed. USA: Cambridge University Press; 2001.
Patel AB, Athavale AM. Sickle cell disease in central India. Indian J Pediatr 2004; 71 (9): 789- 793.
Patra PK, Tripathi S, Khodiar P, Dalla AR, Manikpuri PK, Sinha A. A study of carrier status of sickle cell disease among inmates of central jail Raipur (Chhattisgarh). J Comm Med 2008; 4(1): 11-12.
Patrinos GP, Samperi P, Lo Nigro L, Kollia P, Schiliro G and Papadakis MN (2005) Evidence for the molecular heterogeneity of sickle cell anemia chromosomes bearing the betaS/Benin haplotype. Am J Hematol 80:79-80.
Powars D and Hiti A (1993) Sickle cell anemia. Beta S gene cluster haplotypes as genetic markers for severe disease expression. Am J Dis Child 147:1197-1202.
Rao VR: Genetics and epidemiology of sickle cell anemia in India. Immunohaemtology Bulletin 11(1):39(1988).
RC Jain; Restriction endonuclease analysis of DNA in sickle cell lesions among tribals of Bihar, Madhya Pradesh, Gujarat & Rajasthan. 1989; Indian J Med Res.
Rey, K. S.; Unger, C. A.; Rao, S. P.; Miller, S. T. :Ribozyme-mediated repair of sickle betaglobin
mRNAs in erythrocyte precursors. Science 280: 1593-1596, 1998.
RS Balgir; Aberrant Heterosis in Hemoglobinopathies With Special Reference To Beta- Thalassemia And Structurally Abnormal Hemoglobins E And S In Orissa, India;2007; Division of Human Genetics, Regional Medical Research Centre (ICMR).
RS Balgir; Infant mortality and reproductive wastage associated with different genotypes of haemoglobinopathies in Orissa, India, 2007; Ann Hum Biol.
Sarnaik SA and Ballas SK (2001) Molecular characteristics of pediatric patients with sickle cell
anemia and stroke. Am J Hematol 67:179-182.
Sharma RS et al: Hemoglobinopathies in Western India. Journal of Association of Physician, India 1973; 2: 969-973.
Shrikhande AV et.al., Hematological profile of sickle cell disease in central India. Indian J Hematol Blood Transfus 2006;23:92-98
Treadwell MJ, McClough L, Vichinsky E. Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait. J Natl Med Assoc 2006; 98 (5): 704-710. trial. N Engl J Med 1986; 314:1593-9.
Ugozzoli, L. & Wallace, R.B. 1991. Allele specific polymerase chain reaction Methods. 2:42-48.
Westergren A (1957). "Diagnostic tests: the erythrocyte sedimentation rate range and limitations of the technique". Triangle 3 (1): 20–5.
Wright IS (1962). "The nomenclature of blood clotting factors". Can Med Assoc J 86: 373–4.
Yasmeen Khan et.al., Hematological profile of sickle cell disease:A hospital based study at CIMS, Bilaspur, Chhattisgarh, International Journal of Applied Biology and Pharmaceutical Technology, volume1:issue-2:Aug-Oct-2010
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jayant Kumar, Mitashree Mitra, Manjusha Meshram, Brijesh Kumar Nagwanshi, Prabhat Bhagat, Arun Kumar (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
